PUBLISHER: The Business Research Company | PRODUCT CODE: 1889373
PUBLISHER: The Business Research Company | PRODUCT CODE: 1889373
Electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) refers to the use of AI technologies to collect, process, and interpret patient-reported data captured digitally, including symptoms, treatment experiences, quality of life, and medication adherence. AI enhances ePRO systems by uncovering patterns, predicting health risks, personalizing interventions, and providing actionable insights for clinicians, researchers, and care teams. This approach improves data accuracy, enables earlier issue detection, supports clinical decision-making, and boosts patient engagement in healthcare and clinical trials.
The main components of electronic patient-reported outcomes (ePRO) analytics with AI include software, hardware, and services. ePRO analytics software with AI consists of digital platforms that gather patient-reported information-such as symptoms, side effects, treatment responses, and quality-of-life metrics-and apply AI algorithms to analyze and interpret the data. The solution can be deployed through on-premises or cloud-based models, providing flexible data management options. It is used in clinical trials, patient monitoring, and other healthcare processes, serving end users such as pharmaceutical companies, contract research organizations, hospitals and clinics, academic and research institutions, and other healthcare organizations.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market research report is one of a series of new reports from The Business Research Company that provides electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market statistics, including electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) industry global market size, regional shares, competitors with an electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market share, detailed electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market segments, market trends and opportunities, and any further data you may need to thrive in the electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) industry. This electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market size has grown rapidly in recent years. It will grow from $1.58 billion in 2024 to $1.83 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. Growth in the historic period can be attributed to rising investments in healthcare, an increased focus on patient engagement, strong adoption of digital health technologies, expanding clinical trial activity, and growing demand for real-world evidence (RWE).
The electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market size is expected to see rapid growth in the next few years. It will grow to $3.25 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. Growth in the forecast period can be linked to increasing demand for real-time patient data, a greater emphasis on patient-centric clinical trials, the surge in decentralized and hybrid clinical trial models, rapid digitalization of healthcare infrastructure, and wider acceptance of telemedicine and remote patient monitoring. Major trends expected during the forecast period include the integration of artificial intelligence for advanced analytics, technological advancements in mobile health sensors, innovations in wearable devices, the use of AI in wearables, and continued progress in mobile health sensor technologies.
The increasing acceptance of telemedicine and remote patient monitoring is expected to drive growth in the electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market in the coming years. Telemedicine involves delivering healthcare services through digital communication technologies, while remote patient monitoring entails the continuous collection and analysis of patient health data via connected devices and sensors. The growing use of these technologies is fueled by the demand for convenient, accessible, and timely care. Rising reliance on digital health platforms has accelerated the adoption of advanced tools that enable real-time patient data capture and automated insights in clinical research. This trend supports the expansion of the ePRO analytics with AI market by facilitating continuous, high-quality data collection and intelligent analysis. For example, in December 2023, the UK's National Health Service reported a significant increase in monthly digital interactions, with 33.6 million app users and a 54% rise in monthly logins compared to the previous year, reflecting broader acceptance of digital healthcare engagement. Thus, the growing adoption of telemedicine and remote patient monitoring is propelling the growth of the ePRO analytics with AI market.
Key companies in the ePRO analytics with AI market are introducing innovations such as AI-enabled reporting to improve data accuracy, accelerate clinical insights, and streamline decision-making in clinical trials. AI-enabled reporting uses artificial intelligence to automatically analyze, interpret, and visualize complex datasets, providing faster and more precise insights for informed decision-making. For instance, in January 2025, Medrio, a U.S.-based clinical trial technology provider, launched AI-enabled reporting within its clinical data management system/electronic data capture (CDMS/EDC). This feature simplifies data exploration for study teams managing large volumes of clinical trial data and is embedded directly into the core EDC/CDMS platform, reducing the need for separate reporting tools. Medrio's early adopter program, involving sponsors and CROs, guided feature development to ensure its relevance to real-world trial workflows.
In May 2024, Eli Lilly and Company, a U.S.-based global pharmaceutical firm, acquired Aparito Limited for an undisclosed amount to enhance its digital health and AI-driven ePRO capabilities. The acquisition aimed to strengthen Eli Lilly's capabilities in digital health, decentralized clinical trials, and patient-centric data collection by integrating Aparito's advanced ePRO and AI analytics technologies into its R&D processes. This supports Eli Lilly's strategy to improve clinical trial efficiency and patient engagement through real-time digital monitoring and data-driven insights. Aparito Limited, based in the U.K., provides electronic patient-reported outcomes and digital health solutions leveraging artificial intelligence, machine learning, and wearable technology to remotely capture and analyze patient data through its Atom5 platform.
Major companies operating in the electronic patient-reported outcomes (epro) analytics with artificial intelligence (ai) market are Oracle Health Sciences, IQVIA Inc., Parexel International Corporation, Veeva Systems Inc., Elekta AB Kaiku Health, Clario Inc., Medidata Solutions Inc., Signant Health, eClinical Solutions LLC, Medable Inc., YPrime LLC, Kayentis SAS, uMotif Limited, Clinical Ink Inc., Curebase Inc., AiCure LLC, Climedo Health GmbH, Datacubed Health Inc., OpenClinica LLC, Castor EDC BV
North America was the largest region in the electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market consists of revenues earned by entities by providing services such as artificial intelligence (AI)-enabled electronic patient-reported outcomes (ePRO) platform integration, data analytics and visualization, patient engagement and support, regulatory compliance consulting, system maintenance, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market also includes sales of artificial intelligence (AI)-powered electronic patient-reported outcomes (ePRO) software platform, mobile electronic patient-reported outcomes (ePRO) data collection app, cloud-based electronic patient-reported outcomes (ePRO) analytics dashboard, wearable-integrated patient monitoring tool, and artificial intelligence (AI)-driven clinical trial reporting system. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on electronic patient-reported outcomes (epro) analytics with artificial intelligence (ai) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for electronic patient-reported outcomes (epro) analytics with artificial intelligence (ai) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electronic patient-reported outcomes (epro) analytics with artificial intelligence (ai) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.